Loperamide Hydrochloride And Simethicone Tablet
FDA Label NDC 62207-739

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Granules India Ltd for the product Loperamide Hydrochloride And Simethicone (NDC 62207-739). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding other, active ingredients (in each caplet), purposes, uses, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Other

Drug Facts

Active Ingredients (In Each Caplet)

Loperamide HCl, 2 mg

Simethicone, 125 mg

Purposes

Anti-diarrheal
Anti-gas

Uses

relieves symptoms of diarrhea plus bloating, pressure and cramps, commonly referred to as gas

Warnings

Allergy alert
Do not use if you have ever had a rash or other allergic reaction to loperamide HCl

Heart alert

Taking more than directed can cause serious heart problems or death


Do Not Use

  • if you have bloody or black stool
  • if you have difficulty swallowing

Ask A Doctor Before Use If You Have

  • fever
  • mucus in the stool
  • a history of liver disease
  • a history of abnormal heart rhythm

Ask A Doctor Or Pharmacist Before Use If You Are

 taking a prescription drug. Loperamide may interact with certain prescription drugs.


When Using This Product

 tiredness, drowsiness or dizziness may occur. Be careful when driving or operating machinery.


Stop Use And Ask A Doctor If

  • symptoms get worse
  • diarrhea lasts for more than 2 days
  • you get abdominal swelling or bulging. These may be signs of a serious condition.
  • you have difficulty swallowing the caplet
  • If pregnant or breast-feeding, ask a health professional before use.

Keep Out Of Reach Of Children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

  • drink plenty of clear fluids to help prevent dehydration caused by diarrhea
  • take only on an empty stomach (1 hour before or 2 hours after a meal)
  • take with a full (8 oz.) glass of water
  • find right dose on chart below. If possible, use weight to dose; otherwise, use ag
  • adults and children 12 years and over2 caplets after the first loose stool;

    1 caplet after each subsequent loose stool; but no more than 4

    caplets in 24 hours
    children 9-11 years (60-95 lbs)1 caplet after the first loose stool;

    ½ caplet after each subsequent loose stool; but no more than 3

    caplets in 24 hours
    children 6-8 years (48-59 lbs)1 caplet after the first loose stool;

    ½ caplet after each subsequent loose stool; but no more than 2

    caplets in 24 hours
    children 2-5 years (34 to 47 lbs)ask a doctor
    children under 2 years (up to 33 lbs)do not use

    Other information

    • each caplet contains: calcium 148.40 mg, sodium 1.40 mg
    • store between 20-25°C (68-77°F). Protect from light.
    • for blister: do not use if blister unit is torn or broken

Inactive Ingredients

acesulfame potassium, anhydrous dibasic calcium phosphate, colloidal silicon dioxide, croscarmellose sodium, flavor, microcrystalline cellulose, stearic acid.



Questions or comments?

Contact 1-877-770-3183 Mon-Fri 8:00 AM EST to 5:00 PM PST

Manufactured by:

Granules India Limited

Hyderabad-500 081, INDIA


MADE IN INDIA

Principal Display Panel

Loperamide Hydrochloride and Simethicone Tablets 2 mg/125 mg


ANTI-DIARRHEAL / ANTI-GAS

Multi-Symptom Relief Caplet

Relieves symptoms of diarrhea plus

  • Cramps & Pressure
  • Bloating
  • Gas
  • 12 Caplets *

    *capsule-shaped tablets

    Foil (Loper Simeth Foil)

    Foil (Loper Simeth Foil)

    Carton (Loper Simeth Carton)

    Carton (Loper Simeth Carton)

* Please review the disclaimer below.